Clinical Trial Update: Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 study evaluating azacitidine in combination with cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck; the trial was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• CISPLATIN (cisplatin)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2017-02-27